Joel Palefsky is an Infectious Disease physician affiliated with University of California, San Francisco. OpenAlex indexes 520 publications with 37,428 citations (h-index 98); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 Divisadero St
San Francisco, CA 941153010
Telephone
415-353-7100Registry record last updated 11 Sept 2025.
Clinical trials
- CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Sponsor: University of California, San Francisco
- Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
Sponsor: University of California, San Francisco
- People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202522 payments$22,119openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
21 NIH research awards on record, funded 1991–2025 per NIH RePORTER. The latest:
- CAMPO consortium: HPV-related anogenital disease in people with HIV
University of California, San Francisco
FY2025$369,648U54CA242646 - CAMPO Administrative and Coordinating Core
University of California, San Francisco
FY2025$253,564U54CA242646 - California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
University of California, San Francisco
FY2025$113,778U54CA242646
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- International Anal Neoplasia Society's consensus guidelines for anal cancer screening
International Journal of Cancer
2024 - Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
New England Journal of Medicine
2022 - Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001–2015
JNCI Journal of the National Cancer Institute
2019 - 2016 IANS International Guidelines for Practice Standards in the Detection of Anal Cancer Precursors
Journal of Lower Genital Tract Disease
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”